Scorpion Therapeutics logo

Scorpion Therapeutics Funding & Investors

Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.

scorpiontx.com

Total Amount Raised: $270,000,000

Scorpion Therapeutics Funding Rounds

  • Series B

    $162,000,000

    Series B Investors

    Boxer Capital
    EcoR1 Capital
    Vida Ventures
    Abingworth
    Woodline Partners
    Atlas Venture
    Wellington Management
    Logos Capital
    Invus
    Henderson Global Investors
    Omega Funds
    Nextech Invest
    OrbiMed
    Casdin Capital
    Surveyor Capital
  • Series A

    $108,000,000

    Series A Investors

    Atlas Venture
    Omega Funds
    Vida Ventures
    Abingworth
    Partners HealthCare Innovation
    Mass General Brigham Ventures
Funding info provided by Diffbot.